ASMB vs TEM: fair value comparison
Assembly Biosciences, Inc. and Tempus AI, Inc. · Updated 2026-10-19
ASMB has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. TEM has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, TEM currently ranks higher by quality score. TEM carries the stronger quality grade.
| ASMB | TEM | |
|---|---|---|
| Verdict | No estimate yet | No estimate yet |
| Last price | $20.09 | $64.72 |
| 12-month range | $20.09–$38.50 | $41.55–$91.58 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #163 of 301 Healthcare | #161 of 301 Healthcare |
| Quality grade | F | D |
| Leverage | Low | High |
| Margin trend | Expanding | Expanding |
| Revenue growth | — | High |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Mixed | Mixed |
| 52-week position | The bottom quarter | The lower-middle quarter |
Full single-stock breakdowns: ASMB fair value analysis · TEM fair value analysis